Alexander C Mertens1,2, Rob C Tolboom1, Hana Zavrtanik1,3, Werner A Draaisma4, Ivo A M J Broeders5,6. 1. Department of Surgery, Meander Medical Center, P.O. box 1502, 3800 BM, Amersfoort, The Netherlands. 2. Department of Surgery, University of Twente, Enschede, The Netherlands. 3. Medical Faculty, University of Ljubljana, Ljubljana, Slovenia. 4. Department of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. 5. Department of Surgery, Meander Medical Center, P.O. box 1502, 3800 BM, Amersfoort, The Netherlands. iamj.broeders@meandermc.nl. 6. Department of Surgery, University of Twente, Enschede, The Netherlands. iamj.broeders@meandermc.nl.
Abstract
INTRODUCTION: Published data regarding robot-assisted hiatal hernia repair are mainly limited to small cohorts. This study aimed to provide information on the morbidity and mortality of robot-assisted complex hiatal hernia repair and redo anti-reflux surgery in a high-volume center. MATERIALS AND METHODS: All patients that underwent robot-assisted hiatal hernia repair, redo hiatal hernia repair, and anti-reflux surgery between 2011 and 2017 at the Meander Medical Centre, Amersfoort, the Netherlands were evaluated. Primary endpoints were 30-day morbidity and mortality. Major complications were defined as Clavien-Dindo ≥ IIIb. RESULTS: Primary surgery 211 primary surgeries were performed by two surgeons. The median age was 67 (IQR 58-73) years. 84.4% of patients had a type III or IV hernia (10.9% Type I; 1.4% Type II; 45.5% Type III; 38.9% Type IV, 1.4% no herniation). In 3.3% of procedures, conversion was required. 17.1% of patients experienced complications. The incidence of major complications was 5.2%. Ten patients (4.7%) were readmitted within 30 days. Symptomatic early recurrence occurred in two patients (0.9%). The 30-day mortality was 0.9%. Redo surgery 151 redo procedures were performed by two surgeons. The median age was 60 (IQR 51-68) years. In 2.0%, the procedure was converted. The overall incidence of complications was 10.6%, while the incidence of major complications was 2.6%. Three patients (2.0%) were readmitted within 30 days. One patient (0.7%) experienced symptomatic early recurrence. No patients died in the 30-day postoperative period. CONCLUSIONS: This study provides valuable information on robot-assisted laparoscopic repair of primary or recurrent hiatal hernia and anti-reflux surgery for both patient and surgeon. Serious morbidity of 5.2% in primary surgery and 2.6% in redo surgery, in this large series with a high surgeon caseload, has to be outweighed by the gain in quality of life or relief of serious medical implications of hiatal hernia when counseling for surgical intervention.
INTRODUCTION: Published data regarding robot-assisted hiatal hernia repair are mainly limited to small cohorts. This study aimed to provide information on the morbidity and mortality of robot-assisted complex hiatal hernia repair and redo anti-reflux surgery in a high-volume center. MATERIALS AND METHODS: All patients that underwent robot-assisted hiatal hernia repair, redo hiatal hernia repair, and anti-reflux surgery between 2011 and 2017 at the Meander Medical Centre, Amersfoort, the Netherlands were evaluated. Primary endpoints were 30-day morbidity and mortality. Major complications were defined as Clavien-Dindo ≥ IIIb. RESULTS: Primary surgery 211 primary surgeries were performed by two surgeons. The median age was 67 (IQR 58-73) years. 84.4% of patients had a type III or IV hernia (10.9% Type I; 1.4% Type II; 45.5% Type III; 38.9% Type IV, 1.4% no herniation). In 3.3% of procedures, conversion was required. 17.1% of patients experienced complications. The incidence of major complications was 5.2%. Ten patients (4.7%) were readmitted within 30 days. Symptomatic early recurrence occurred in two patients (0.9%). The 30-day mortality was 0.9%. Redo surgery 151 redo procedures were performed by two surgeons. The median age was 60 (IQR 51-68) years. In 2.0%, the procedure was converted. The overall incidence of complications was 10.6%, while the incidence of major complications was 2.6%. Three patients (2.0%) were readmitted within 30 days. One patient (0.7%) experienced symptomatic early recurrence. No patients died in the 30-day postoperative period. CONCLUSIONS: This study provides valuable information on robot-assisted laparoscopic repair of primary or recurrent hiatal hernia and anti-reflux surgery for both patient and surgeon. Serious morbidity of 5.2% in primary surgery and 2.6% in redo surgery, in this large series with a high surgeon caseload, has to be outweighed by the gain in quality of life or relief of serious medical implications of hiatal hernia when counseling for surgical intervention.
Entities:
Keywords:
Anti-reflux; Hiatal hernia; Redo; Reflux; Robotics; Surgery
Authors: Gyusung I Lee; Mija R Lee; Tameka Clanton; Tamera Clanton; Erica Sutton; Adrian E Park; Michael R Marohn Journal: Surg Endosc Date: 2013-10-03 Impact factor: 4.584
Authors: Chris Braumann; Christoph A Jacobi; Charalambos Menenakos; Mahmoud Ismail; Jens C Rueckert; Joachim M Mueller Journal: Surg Laparosc Endosc Percutan Tech Date: 2008-06 Impact factor: 1.719
Authors: Lee J Moore; Mark R Wilson; John S McGrath; Elizabeth Waine; Rich S W Masters; Samuel J Vine Journal: Surg Endosc Date: 2014-11-27 Impact factor: 4.584
Authors: James D Luketich; Katie S Nason; Neil A Christie; Arjun Pennathur; Blair A Jobe; Rodney J Landreneau; Matthew J Schuchert Journal: J Thorac Cardiovasc Surg Date: 2009-12-11 Impact factor: 5.209
Authors: Tobias Gehrig; A Mehrabi; L Fischer; H Kenngott; U Hinz; C N Gutt; Beat P Müller-Stich Journal: Langenbecks Arch Surg Date: 2012-07-31 Impact factor: 3.445
Authors: B P Müller-Stich; M A Reiter; A Mehrabi; M N Wente; L Fischer; J Köninger; C N Gutt Journal: Langenbecks Arch Surg Date: 2009-01-23 Impact factor: 3.445
Authors: Chang Min Lee; Joong-Min Park; Han Hong Lee; Kyong Hwa Jun; Sungsoo Kim; Kyung Won Seo; Sungsoo Park; Jong-Han Kim; Jin-Jo Kim; Sang-Uk Han Journal: Ann Surg Treat Res Date: 2018-05-29 Impact factor: 1.859
Authors: Basem G Soliman; Duc T Nguyen; Edward Y Chan; Ray K Chihara; Leonora M Meisenbach; Edward A Graviss; Min P Kim Journal: Surg Endosc Date: 2019-08-05 Impact factor: 4.584
Authors: Alexander Wilhelm; Fabio Nocera; Fiorenzo V Angehrn; Martin Bolli; Romano Schneider; Luca Koechlin; Diana L Daume; Lana Fourie; Daniel Steinemann; Markus von Flüe; Ralph Peterli Journal: Surg Endosc Date: 2021-02-01 Impact factor: 4.584
Authors: Renske A B Oude Nijhuis; Margot van der Hoek; Jeroen M Schuitenmaker; Marlies P Schijven; Werner A Draaisma; Andreas J P M Smout; Albert J Bredenoord Journal: United European Gastroenterol J Date: 2020-08-24 Impact factor: 4.623